A introdução de novos medicamentos no mercado farmacêutico brasileiro: exame em um cenário de precificação regulada

Authors

  • João Paulo Carvalho UNESP e ABEIN https://orcid.org/0000-0002-4864-0141
  • Lia Hasenclever Doutora em Engenharia de Produção (UFRJ). Docente da Universidade Cândido Mendes-Campos e Pesquisadora do GEI/UFRJ https://orcid.org/0000-0003-1384-6323
  • Rogério Gomes Doutor em Ciências Econômicas (UNICAMP). Docente do Programa de Pós-Graduação em Economia/UNESP e Coordenador do GEEIN/UNESP

DOI:

https://doi.org/10.1590/fwerdr82

Abstract

The aim is to identify the influence of the CMED price regulation policy for new drugs (new, new reference, new biological) in contemplating the interests of companies, national and transnational, and favoring the consumer. The methodology contemplates the creation of a basis for comparison between factory prices and maximum consumer prices, of new drugs of therapeutic class L of the Anatomical Therapeutic Chemical classification, introduced in the market between April 2017 and August 2020, comparing them with the prices practiced by pharmacies, in January 2021, taken from Consulta Remédios. The analysis showed that: (i) the new principles are mostly introduced by transnationals; (ii) sector agents have a large margin for commercialization; (iii) regulation is not respected by retailers; and (iv) such policies do not encourage companies to invest in R&D in Brazil. There is a need to review the CMED policy, as there are failures in the market.

Published

2025-09-17

Issue

Vol. 34 No. 3 (2025): Economia e Sociedade

Section

Articles

License

Authors who publish in this journal agree to the following terms: Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License, which allows the sharing of the work with acknowledgment of authorship and initial publication in this journal. Authors are authorized to enter into additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publish in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. All content of the journal, except where identified, is licensed under a Creative Commons Attribution BY-NC License.